RxDoctor Payments Data

Mohamed Gad

Cardiovascular Disease · Houston, TXNPI 1629539333

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (53.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Abbott at 28.1% of the total. Among cardiovascular disease clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,399in general payments, 2019–2025

Across 309 payments — averaging $95.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$8K
  • Medtronic$8K
  • Boston Scientific$5K
  • Medical Device Business Services, Inc.$5K
  • Biosense Webster, Inc.$4K
  • Biotronik Inc.$427
  • plus $275 from 4 others

What the payments were for

  • Travel & lodging$15,58153%
  • Food & beverage$11,58039%
  • Education$2,2388%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,399 in reported general payments places this provider in the 90th percentile of 1,515 cardiovascular disease providers in Texas.

See all cardiovascular disease providers in Texas →

Other cardiovascular disease in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →